Changes of psychosocial factors, enteric mucosal mast cells and 5-hydroxytryptamine in irritable bowel syndrome

World Chinese Journal of Digestology

Volumn 15, Issue 1, 2007, Pages 46-50

  Chen, Wen Ke ^a   Zou, Yi You ^b   Li, Fu Jun ^b   Luo, Dan ^c  

^a PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c JIANGMEN CENTRAL HOSPITAL   (China)

Author keywords

5 hydroxytryptamine; Irritable bowel syndrome; Mast cell; Pathogenesis; Psychosocial factors

Indexed keywords

METHYLTESTOSTERONE;

ARTICLE; CECUM; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DEGRANULATION; DIARRHEA; ELECTROCHEMICAL DETECTION; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; IRRITABLE COLON; MAST CELL; PATHOGENESIS; SOCIAL PSYCHOLOGY;

EID: 33846450269     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v15.i1.46     Document Type: Article

References (31)

1. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377-1390
2. Smith RC, Greenbaum DS, Vancouver JB, Henry RC, Reinhart MA, Greenbaum RB, Dean HA, Mayle JE. Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome. Gastroenterology 1990; 98: 293-301
3. Drossman DA, Creed FH, Olden KW, Svedlund J, Toner BB, Whitehead WE. Psychosocial aspects of the functional gastrointestinal disorders. Gut 1999; 45 Suppl 2: II25-30
4. Chinese source
5. Chinese source
6. Lydiard RB, Falsetti SA. Experience with anxiety and depression treatment studies: implications for designing irritable bowel syndrome clinical trials. Am J Med 1999; 107: 65S-73S
7. Chinese source
8. Heymann-Monnikes I, Arnold R, Florin I, Herda C, Melfsen S, Monnikes H. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 981-994
9. Church MK, Clough GF. Human skin mast cells: in vitro and in vivo studies. Ann Allergy Asthma Immunol 1999; 83: 471-475
10. McKay DM, Bienenstock J. The interaction between mast cells and nerves in the gastrointestinal tract. Immunol Today 1994; 15: 533-538
11. Bradding P, Holgate ST. Immunopathology and human mast cell cytokines. Crit Rev Oncol Hematol 1999; 31: 119-133
12. O'Sullivan M, Clayton N, Breslin NP, Harman I, Bountra C, McLaren A, O'Morain CA. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000; 12: 449-457
13. Chinese source
14. Chinese source
15. Coelho AM, Fioramonti J, Bueno L. Mast cell degranulation induces delayed rectal allodynia in rats: role of histamine and 5-HT. Dig Dis Sci 1998; 43: 727-737
16. Addolorato G, Marsigli L, Capristo E, Caputo F, Dall'Aglio C, Baudanza P. Anxiety and depression: a common feature of health care seeking patients with irritable bowel syndrome and food allergy. Hepatogastroenterology 1998; 45: 1559-1564
17. Kuemmerle JF, Murthy KS, Grider JR, Martin DC, Makhlouf GM. Coexpression of 5-HT2A and 5-HT4 receptors coupled to distinct signaling pathways in human intestinal muscle cells. Gastroenterology 1995; 109: 1791-1800
18. Grider JR, Foxx-Orenstein AE, Jin JG. 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology 1998; 115: 370-380
19. Taiwo YO, Levine JD. Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience 1992; 48: 485-490
20. Ebersberger A, Anton F, Tolle TR, Zieglgansberger W. Morphine, 5-HT2 and 5-HT3 receptor antagonists reduce c-fos expression in the trigeminal nuclear complex following noxious chemical stimulation of the rat nasal mucosa. Brain Res 1995; 676: 336-342
21. Richardson BP, Engel G, Donatsch P, Stadler PA. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 1985; 316: 126-131
22. Kozlowski CM, Green A, Grundy D, Boissonade FM, Bountra C. The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat. Gut 2000; 46: 474-480
23. Bearcroft CP, Perrett D, Farthing MJ. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 1998; 42: 42-46
24. Chinese source
25. Chinese source
26. Chinese source
27. Chinese source
28. Gorard DA, Gomborone JE, Libby GW, Farthing MJ. Intestinal transit in anxiety and depression. Gut 1996; 39: 551-555
29. Castagliuolo I, Lamont JT, Qiu B, Fleming SM, Bhaskar KR, Nikulasson ST, Kornetsky C, Pothoulakis C. Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells. Am J Physiol 1996; 271: G884-892
30. Miyata K, Ito H, Fukudo S. Involvement of the 5-HT3 receptor in CRH-induce defecation in rats. Am J Physiol 1998; 274: G827-831
31. Castagliuolo I, Leeman SE, Bartolak-Suki E, Nikulasson S, Qiu B, Carraway RE, Pothoulakis C. A neurotensin antagonist, SR 48692, inhibits colonic responses to immobilization stress in rats. Proc Natl Acad Sci USA 1996; 93: 12611-12615